Results 141 to 150 of about 37,214 (250)

Hijacking the bone niche: mechanistic insights into bone metastasis in breast cancer. [PDF]

Bone Res
Wu J, Deng M, Ye F, Deng W, Wu Z, Zheng X, Song C, Zou Y, Tang H.   +8 more
europepmc   +1 more source

Systemic medications associate with surgically treated cataract among adults over 50 years in Finland

Acta Ophthalmologica, Volume 104, Issue 6, Page e630-e647, September 2026.
Abstract Purpose To identify associations between systemic drugs and cataract surgery in Finland. Methods A historic cohort study based on administrative data. Endpoint event was cataract surgery. Use of drugs in question was based on redeemed prescriptions and consisted of 156 drugs.
Antti Riikonen, Jari Haukka, Tuomas Lilius, Sirpa Loukovaara   +3 more
wiley   +1 more source

Comparative efficacy and safety of odanacatib, abaloparatide, denosumab, teriparatide, and bisphosphonates for male osteoporosis: a systematic review and network meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Lu C, Zhang L, Xue C, Liao M, Fei J, Chen X, Wang L.   +6 more
europepmc   +1 more source

Type 2 Diabetes Is Associated With Increased Complications and Mortality After Hip Fracture in Older Adults Aged 60 Years or Older

Diabetes, Obesity and Metabolism, Volume 28, Issue 9, Page 8084-8093, September 2026.
ABSTRACT Aims Type 2 diabetes (T2D) is associated with increased hip fracture risk. We evaluated the impact of T2D on post‐hip fracture outcomes, which is less well described. Materials and Methods Individuals aged ≥ 60 years hospitalised for hip fractures between 2011 and 2020 were identified from the territory‐wide electronic health records of Hong ...
Xincheng Zou, Manju Chandran, Xi Xiong, Chi‐Ho Lee, Wing‐Sun Chow, Carol H. Y. Fong, Lawrence C. M. Lau, Ka‐Shing Cheung, Carlos K. H. Wong, Kathryn C. B. Tan, Yu‐Cho Woo, Karen S. L. Lam, David T. W. Lui   +12 more
wiley   +1 more source

Comments on 'Bisphosphonate and statin: adverse effects of co-medication on wound healing in in vitro models of periodontal tissues'. [PDF]

Acta Odontol Scand
Szaraz D, Perina V, Borilova Linhartova P.   +2 more
europepmc   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists and Incident Major Adverse Liver Outcomes in People With Type 2 Diabetes and Metabolic Dysfunction‐Associated Steatotic Liver Disease

Diabetes, Obesity and Metabolism, Volume 28, Issue 9, Page 8277-8287, September 2026.
ABSTRACT Aims Treatment options for metabolic dysfunction‐associated steatotic liver disease (MASLD) are limited. While glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) and sodium‐glucose cotransporter‐2 (SGLT‐2) inhibitors improve cardiovascular outcomes, comparative effectiveness on liver‐related outcomes remains unclear.
Gregor A. Maier, Ramon A. Hofmann, Michael Roden, Wolfgang Rathmann, Oliver Kuss   +4 more
wiley   +1 more source

Effects of Bisphosphonates on Bone Micro-Architecture of Children With Duchenne Muscular Dystrophy: A Prospective Comparative Study. [PDF]

J Cachexia Sarcopenia Muscle
Wang S, Dai Y, Meng L, Zhang Y, Sun L, Wang Y, Wang O, Jiang Y, Xia W, Xing X, Yu W, Li M.   +11 more
europepmc   +1 more source

Mesotherapy With Lidocaine and Ketamine in Complex Regional Pain Syndrome Type 1: A Randomized Double‐Blind Trial

Pain Practice, Volume 26, Issue 7, September 2026.
ABSTRACT Background Complex regional pain syndrome type 1 (CRPS1) is a disabling pain syndrome whose treatment remains challenging. Mesotherapy is a therapeutic method involving the injection of low doses of active substances through the skin. No studies assessed mesotherapy in CRPS1 patients.
Philippe Lafuma, Laurent Magaud, Amna Abichou‐Klich, Muriel Rabilloud, Julien Wegrzyn, Christian Baude, Pascal Rippert, Myriam Kaou, Julie Haesebaert, Frédéric Rongieras, Chloé Marchand, Carole Dhelens, Olivia Febvey‐Combes   +12 more
wiley   +1 more source

Intralesional Triamcinolone versus Oral Bisphosphonate for Benign Cystic Bone Lesions: A Prospective Comparative Study of Radiological and Pain Outcomes. [PDF]

J Orthop Case Rep
Kalme B, Kumar A, Gupta RK.
europepmc   +1 more source

Relationship between bisphosphonate use and risks of recurrence and mortality among hormone receptor–positive and triple‐negative breast cancer patients

Cancer, Volume 132, Issue 16, 15 August 2026.
Abstract Background Bisphosphonates (BPs) are routinely used as an adjuvant therapy for breast cancer to reduce the risk of bone recurrences given their anti‐resorptive effects on bones and antitumor characteristics. However, there remains limited evidence regarding their utility across different subtypes. Methods In this population‐based cohort study,
Liuye Huang, Linda S. Cook, Mei‐Tzu C. Tang, David R. Doody, Ulrike Peters, Wei Sun, Jeroen R. Huyghe, Kathleen E. Malone, Christopher I. Li   +8 more
wiley   +1 more source